Reuters: Roche, Genentech in talks on $47 billion deal

[dave]

Roche, Genentech in talks on $47 billion deal
      
   
      

NEW YORK (Reuters) - Merck &amp; Co Inc said on Monday it would acquire Schering-Plough Corp for $41.1 billion, uniting the makers of cholesterol drugs Zetia and Vytorin in the second megadeal for big pharma in weeks.<div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login